155 related articles for article (PubMed ID: 36398883)
1. Fatal Retroperitoneal Bleeding in Neurofibromatosis Type 1: A Clinically Occult Complication.
Voudouri M; Chambers M; Baker ML; Kerr DA
Am J Forensic Med Pathol; 2023 Mar; 44(1):63-67. PubMed ID: 36398883
[TBL] [Abstract][Full Text] [Related]
2. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots and Freckling. Part II. Other Skin Manifestations Characteristic of NF1. NF1 and Cancer.
Hernández-Martín A; Duat-Rodríguez A
Actas Dermosifiliogr; 2016; 107(6):465-73. PubMed ID: 26956402
[TBL] [Abstract][Full Text] [Related]
3. An Update on Neurofibromatosis Type 1: Not Just Café-au-Lait Spots, Freckling, and Neurofibromas. An Update. Part I. Dermatological Clinical Criteria Diagnostic of the Disease.
Hernández-Martín A; Duat-Rodríguez A
Actas Dermosifiliogr; 2016; 107(6):454-64. PubMed ID: 26979265
[TBL] [Abstract][Full Text] [Related]
4. A novel NF1 mutation in a Chinese patient with giant café-au-lait macule in neurofibromatosis type 1 associated with a malignant peripheral nerve sheath tumor and bone abnormality.
Tong HX; Li M; Zhang Y; Zhu J; Lu WQ
Genet Mol Res; 2012 Aug; 11(3):2972-8. PubMed ID: 22869071
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and follow-up protocol for adult patients with neurofibromatosis type 1 in a Spanish reference unit.
Solares I; Vinal D; Morales-Conejo M
Rev Clin Esp (Barc); 2022 Oct; 222(8):486-495. PubMed ID: 35688675
[TBL] [Abstract][Full Text] [Related]
6. Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience.
Kokkinou E; Roka K; Alexopoulos A; Tsina E; Nikas I; Krallis P; Thanopoulou I; Nasi L; Makrygianni E; Tsoutsou E; Kosma K; Tsipi M; Tzetis M; Frysira H; Kattamis A; Pons R
Postgrad Med; 2019 Sep; 131(7):445-452. PubMed ID: 31443616
[TBL] [Abstract][Full Text] [Related]
7. [Neurofibromas in Type I Neurofibromatosis. Description of a clinical case and literature review].
Del Puerto C; Aspee M; Downey C
Andes Pediatr; 2022 Oct; 93(5):741-748. PubMed ID: 37906895
[TBL] [Abstract][Full Text] [Related]
8. Mandibular neurofibroma with osseous deformities in a 3-year-old child with neurofibromatosis type 1: A case report presentation and diagnosis.
Aloyouny AY; Albagieh HN; Alweteid AS; Alsheddi MA
Niger J Clin Pract; 2021 Nov; 24(11):1755-1757. PubMed ID: 34782519
[TBL] [Abstract][Full Text] [Related]
9. Giant café-au-lait macule in neurofibromatosis 1: a type 2 segmental manifestation of neurofibromatosis 1?
Yang CC; Happle R; Chao SC; Yu-Yun Lee J; Chen W
J Am Acad Dermatol; 2008 Mar; 58(3):493-7. PubMed ID: 18280349
[TBL] [Abstract][Full Text] [Related]
10. [Lisch nodule in neurofibromatosis type 1].
Abaloun Y; Ajhoun Y
Pan Afr Med J; 2017; 27():218. PubMed ID: 28979620
[TBL] [Abstract][Full Text] [Related]
11. Genotype-phenotype associations in neurofibromatosis type 1 (NF1): an increased risk of tumor complications in patients with NF1 splice-site mutations?
Alkindy A; Chuzhanova N; Kini U; Cooper DN; Upadhyaya M
Hum Genomics; 2012 Aug; 6(1):12. PubMed ID: 23244495
[TBL] [Abstract][Full Text] [Related]
12. Analysis of neurofibromatosis 1 (NF1) lesions by body segment.
Palmer C; Szudek J; Joe H; Riccardi VM; Friedman JM
Am J Med Genet A; 2004 Mar; 125A(2):157-61. PubMed ID: 14981716
[TBL] [Abstract][Full Text] [Related]
13. Genetic analyses of mosaic neurofibromatosis type 1 with giant café-au-lait macule, plexiform neurofibroma and multiple melanocytic nevi.
Hida T; Idogawa M; Okura M; Sugita S; Sugawara T; Sasaki Y; Tokino T; Yamashita T; Uhara H
J Dermatol; 2020 Jun; 47(6):658-662. PubMed ID: 32246533
[TBL] [Abstract][Full Text] [Related]
14. A fortuitous discovery of a neurofibroma in a female patient with type 1 neurofibromatosis: a case report.
Harrabi F; Methnani J; Houssem A; Abdelkader M; Mehdi BL; Amine SM; Mohamed BM; Ali BA
J Int Med Res; 2022 Dec; 50(12):3000605221139716. PubMed ID: 36510447
[TBL] [Abstract][Full Text] [Related]
15. Neurofibromatosis-I Presentating with Multiple Spinal and Intracranial Neurofibromas.
Tripathi S; Pandey CB; Dubey TN; Singh P
J Assoc Physicians India; 2016 Feb; 64(2):72-74. PubMed ID: 27730789
[TBL] [Abstract][Full Text] [Related]
16. [Imaging features of neurofibromatosis type 1].
Jacques C; Dietemann JL
J Neuroradiol; 2005 Jun; 32(3):180-97. PubMed ID: 16134300
[TBL] [Abstract][Full Text] [Related]
17. Treatment With Selumetinib for Café-au-Lait Macules and Plexiform Neurofibroma in Pediatric Patients With Neurofibromatosis Type 1.
Guo YX; Wang HX; Wang SS; Croitoru D; Piguet V; Gao XH; Xu XG
JAMA Dermatol; 2024 Mar; 160(3):366-368. PubMed ID: 38198164
[TBL] [Abstract][Full Text] [Related]
18. Malignant Peripheral Nerve Sheath Tumor in an Army Reservist With Neurofibromatosis Type 1.
Kou CJ; Rendo M; Broadwater DR; Beeler B
Mil Med; 2021 May; 186(5-6):e626-e631. PubMed ID: 33180928
[TBL] [Abstract][Full Text] [Related]
19. An update on choroidal abnormalities and retinal microvascular changes in neurofibromatosis type 1.
Mallone F; Lucchino L; Giustini S; Lambiase A; Moramarco A
Orphanet J Rare Dis; 2022 Jun; 17(1):223. PubMed ID: 35698197
[TBL] [Abstract][Full Text] [Related]
20. A case of non-Hodgkin's lymphoma in a patient with neurofibromatosis type 1.
Kim SJ; Seo JH; Lee SW; Han E; Lee ES; Cha SH; Seo BK
Korean J Intern Med; 2003 Sep; 18(3):202-5. PubMed ID: 14619393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
